Pediatric cardiomyopathy program receives top honors

Published on March 17th, 2022 by Christina Echegaray.

Monroe Carell Jr. Children’s Hospital at Vanderbilt has been named an accredited center of care by the Children’s Cardiomyopathy Foundation, a national nonprofit committed to improving the health outcomes and quality of life for children with cardiomyopathy.

The Pediatric Cardiomyopathy Program at Children’s Hospital is one of only a few such programs in Tennessee.

Cardiomyopathy is a chronic heart disease that affects how the heart pumps blood through the body.

Children’s Hospital received this recognition for providing consistent high-quality cardiac care and

specialized disease management to children with cardiomyopathy.

The program also was recently named a center of excellence for hypertrophic cardiomyopathy by the Hypertrophic Cardiomyopathy Association (HCMA), a nonprofit organization that provides support, advocacy and education to patients and health care professionals. The Pediatric Hypertrophic Cardiomyopathy Program at Vanderbilt is one of a few pediatric programs in the country to receive HCMA center of excellence designation.

Pediatric cardiomyopathy is a complex and variable disease with only a quarter of those diagnosed having a known cause. The disease requires a team approach to providing comprehensive care.